compound 5 [PMID: 30894487]   Click here for help

GtoPdb Ligand ID: 10398

PDB Ligand Antimalarial Ligand
Compound class: Synthetic organic
Comment: Compound 5 is the lead identified from a target-based approach to develop new compounds with antimalarial activity [1].

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 79.54
Molecular weight 355.1
XLogP 3.64
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Fc1ccc2c(c1)c(=O)cc(o2)C(=O)NCC1(O)CCC(CC1)(F)F
Isomeric SMILES Fc1ccc2c(c1)c(=O)cc(o2)C(=O)NCC1(O)CCC(CC1)(F)F
InChI InChI=1S/C17H16F3NO4/c18-10-1-2-13-11(7-10)12(22)8-14(25-13)15(23)21-9-16(24)3-5-17(19,20)6-4-16/h1-2,7-8,24H,3-6,9H2,(H,21,23)
InChI Key PJBRCGHQNUWERQ-UHFFFAOYSA-N
Guide to Malaria Pharmacology Comments
Compound 5 was optimized, using a structure-based aproach, from the small molecule hit identified from a series of selective inhibitors of apicomplexan lysine--tRNA ligase (lysyl-tRNA synthetase) [1]. Plasmodium lysine--tRNA ligase (PfKRS1) has been validated as a target for antimalarial drug development when it was shown to be the target of the natural product cladosporin [2].